Clinical Trial

Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an open-label, randomized study evaluating the short-term glycemic effects of two concentrations of liquid metformin formulations (100 mg/mL and 250 mg/mL) compared with standard immediate-release metformin tablets in healthy adult subjects. Participants will receive single or short-term doses of study treatments in a randomized sequence. Blood glucose measurements and other glycemic indicators will be collected to assess short-term pharmacodynamic effects. Safety and tolerability will also be monitored.
Trial Details
NCT Number NCT07300059
Lead Sponsor Aspargo Labs, Inc
Conditions Healthy Volunteers
Enrollment 24 participants
Start Date 2026-07-15
Primary Completion 2026-08-15 (estimated)
Study Completion 2026-08-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-23